Business Context and Reporting Period
Company: Processa Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 29, 2021
Event: Regulation FD Disclosure regarding a corporate presentation delivered at the LD Micro "Zooming with LD Micro" virtual investor event.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of a corporate presentation and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes versus prior periods are detailed in this filing. The document references a presentation (Exhibit 99.1) which may contain operational updates, but the text of the 8-K itself contains no comparative financial data.
Guidance, Outlook, and Risks
- Management Commentary: The company presented updates at a virtual investor event on July 29, 2021. The full presentation is available on the company's website under the "Investors" section.
- Forward-Looking Statements: Processa explicitly states it undertakes no duty or obligation to publicly update or revise the information contained in this report or the attached presentation, though it may do so through future filings or press releases.
- Disclosure Method: The company notes it routinely uses its website to disclose material non-public information in compliance with Regulation FD.
Key Facts for Investor Verification
- Verify the content of the "July 2021 Corporate Presentation" (Exhibit 99.1) on the company website for specific operational or financial details not included in this 8-K.
- Confirm the company's status as an emerging growth company (indicated as unchecked in the filing).
- Note that the information in this Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act.